Literature DB >> 21837400

[Clinical aspects of premalignant lesions of the upper gastrointestinal tract].

H-J Meyer1.   

Abstract

A variety of somatic genetic and epigenetic aberrations are discussed in the multistep carcinogenesis of tumors of the upper gastrointestinal tract but specific genetic changes are still unknown. Primary prevention of cancer is important and includes the control of causal endo- and exogenous factors. Screening endoscopies to detect premalignant lesions or early carcinoma cannot be recommended in the Western world. The incidence of preinvasive neoplasia, above all the high-grade intraepithelial neoplasia, in Barrett's esophagus or stomach is as low as 4.0 or 0.6%, respectively. Secondary prevention of cancer after changes of the mucosa should be performed by endoscopic diagnosis and treatment performing biopsies or resection of the lesion. After histological diagnosis of a high-grade intraepithelial neoplasia, complete resection of these lesions including complete ablation of Barrett's mucosa should be carried out. On the basis of an exact pathological report, close cooperation between endoscopist and surgeon seems to be necessary to find out the best individual therapy with curative intent.

Entities:  

Mesh:

Year:  2011        PMID: 21837400     DOI: 10.1007/s00292-011-1471-x

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  17 in total

Review 1.  Gastric preneoplastic lesions and epithelial dysplasia.

Authors:  Gregory Y Lauwers; Amitabh Srivastava
Journal:  Gastroenterol Clin North Am       Date:  2007-12       Impact factor: 3.806

2.  [German S3-guideline "Diagnosis and treatment of esophagogastric cancer"].

Authors:  M Moehler; S-E Al-Batran; T Andus; M Anthuber; J Arends; D Arnold; D Aust; P Baier; G Baretton; J Bernhardt; H Boeing; E Böhle; C Bokemeyer; J Bornschein; W Budach; E Burmester; K Caca; W A Diemer; C F Dietrich; M Ebert; A Eickhoff; C Ell; J Fahlke; H Feussner; R Fietkau; W Fischbach; W Fleig; M Flentje; H E Gabbert; P R Galle; M Geissler; I Gockel; U Graeven; L Grenacher; S Gross; J T Hartmann; M Heike; V Heinemann; B Herbst; T Herrmann; S Höcht; R D Hofheinz; H Höfler; T Höhler; A H Hölscher; M Horneber; J Hübner; J R Izbicki; R Jakobs; C Jenssen; S Kanzler; M Keller; R Kiesslich; G Klautke; J Körber; B J Krause; C Kuhn; F Kullmann; H Lang; H Link; F Lordick; K Ludwig; M Lutz; R Mahlberg; P Malfertheiner; S Merkel; H Messmann; H-J Meyer; S Mönig; P Piso; S Pistorius; R Porschen; T Rabenstein; P Reichardt; K Ridwelski; C Röcken; I Roetzer; P Rohr; W Schepp; P M Schlag; R M Schmid; H Schmidberger; W-H Schmiegel; H-J Schmoll; G Schuch; C Schuhmacher; K Schütte; W Schwenk; M Selgrad; A Sendler; J Seraphin; T Seufferlein; M Stahl; H Stein; C Stoll; M Stuschke; A Tannapfel; R Tholen; P Thuss-Patience; K Treml; U Vanhoefer; M Vieth; H Vogelsang; D Wagner; U Wedding; A Weimann; H Wilke; C Wittekind
Journal:  Z Gastroenterol       Date:  2011-04-07       Impact factor: 2.000

3.  Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients.

Authors:  Roos E Pouw; Stefan Seewald; Joep J Gondrie; Pierre H Deprez; Hubert Piessevaux; Heiko Pohl; Thomas Rösch; Nib Soehendra; Jacques J Bergman
Journal:  Gut       Date:  2010-06-04       Impact factor: 23.059

4.  Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study.

Authors:  Pieter J F de Jonge; Mark van Blankenstein; Caspar W N Looman; Mariël K Casparie; Gerrit A Meijer; Ernst J Kuipers
Journal:  Gut       Date:  2010-08       Impact factor: 23.059

Review 5.  Squamous dysplasia and other precursor lesions related to esophageal squamous cell carcinoma.

Authors:  Michio Shimizu; Shinichi Ban; Robert D Odze
Journal:  Gastroenterol Clin North Am       Date:  2007-12       Impact factor: 3.806

6.  The risk of esophageal adenocarcinoma after antireflux surgery.

Authors:  Jesper Lagergren; Weimin Ye; Pernilla Lagergren; Yunxia Lu
Journal:  Gastroenterology       Date:  2010-01-18       Impact factor: 22.682

7.  Gastrointestinal epithelial neoplasia: Vienna revisited.

Authors:  M F Dixon
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

8.  Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.

Authors:  Annemarie C de Vries; Nicole C T van Grieken; Caspar W N Looman; Mariël K Casparie; Esther de Vries; Gerrit A Meijer; Ernst J Kuipers
Journal:  Gastroenterology       Date:  2008-01-30       Impact factor: 22.682

Review 9.  Confocal endomicroscopy for in vivo microscopic analysis of upper gastrointestinal tract premalignant and malignant lesions.

Authors:  Cristian Gheorghe; Razvan Iacob; Gabriel Becheanu; Mona Dumbrav Abreve
Journal:  J Gastrointestin Liver Dis       Date:  2008-03       Impact factor: 2.008

Review 10.  Pathology of upper gastrointestinal malignancies.

Authors:  Mario Sarbia; Karl Friedrich Becker; Heinz Höfler
Journal:  Semin Oncol       Date:  2004-08       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.